Meaghan Jones is a seasoned global biopharmaceutical executive specializing in commercial strategy, drug development, and business growth in oncology and infectious diseases. They played a pivotal role in the expansion of Pfizer's oncology franchise, boosting revenue from $1.3 billion in 2011 to $12.1 billion in 2022, with significant achievements including the successful launches of IBRANCE and Xtandi. Currently serving as Vice President of Commercial Development at CSL Seqirus, they continue to lead initiatives in the biopharmaceutical sector. Meaghan holds a Master of Public Health from Columbia University and a Bachelor’s degree in Biology from Dartmouth College.
This person is not in any teams
This person is not in any offices